KIT and pulmonary arterial hypertension: Previously, AMD3100 treatment was shown to attenuate pulmonary angiogenesis by reducing the number of c-Kit+ cells in rat lungs [34], and reduce the number of proliferating c-Kit+ SMA+ cells in PAH rats [12].